These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 36009486)

  • 1. The Role of Rab Proteins in Parkinson's Disease Synaptopathy.
    Bellucci A; Longhena F; Spillantini MG
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab GTPases: The Key Players in the Molecular Pathway of Parkinson's Disease.
    Shi MM; Shi CH; Xu YM
    Front Cell Neurosci; 2017; 11():81. PubMed ID: 28400718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease.
    Bellucci A; Bubacco L; Longhena F; Parrella E; Faustini G; Porrini V; Bono F; Missale C; Pizzi M
    Front Aging Neurosci; 2020; 12():68. PubMed ID: 32265684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contribution of
    Longhena F; Faustini G; Missale C; Pizzi M; Spano P; Bellucci A
    Neural Plast; 2017; 2017():5012129. PubMed ID: 28133550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of synaptic endocytic trafficking in Parkinson's disease.
    Ng XY; Cao M
    Neural Regen Res; 2024 Dec; 19(12):2649-2660. PubMed ID: 38595283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2-Related Parkinson's Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis.
    Rivero-Ríos P; Romo-Lozano M; Fasiczka R; Naaldijk Y; Hilfiker S
    Front Neurosci; 2020; 14():556. PubMed ID: 32581693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's: A Disease of Aberrant Vesicle Trafficking.
    Singh PK; Muqit MMK
    Annu Rev Cell Dev Biol; 2020 Oct; 36():237-264. PubMed ID: 32749865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease.
    Gao Y; Wilson GR; Stephenson SEM; Bozaoglu K; Farrer MJ; Lockhart PJ
    Mov Disord; 2018 Feb; 33(2):196-207. PubMed ID: 29315801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
    Zaltieri M; Longhena F; Pizzi M; Missale C; Spano P; Bellucci A
    Parkinsons Dis; 2015; 2015():108029. PubMed ID: 25918668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.
    Bridi JC; Hirth F
    Front Neurosci; 2018; 12():80. PubMed ID: 29515354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
    Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
    Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.
    Bellucci A; Antonini A; Pizzi M; Spano P
    Front Aging Neurosci; 2017; 9():330. PubMed ID: 29066967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.
    Rosh I; Tripathi U; Hussein Y; Rike WA; Djamus J; Shklyar B; Manole A; Houlden H; Winkler J; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 Feb; 10(1):38. PubMed ID: 38374278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic Studies.
    Ebanks K; Lewis PA; Bandopadhyay R
    Front Neurosci; 2019; 13():1381. PubMed ID: 31969802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?
    O'Hara DM; Pawar G; Kalia SK; Kalia LV
    Front Neurosci; 2020; 14():577. PubMed ID: 32625052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF2 Affects Parkinson's Disease-Associated Molecular Networks Through Exosomal Rab8b/Rab31.
    Kumar R; Donakonda S; Müller SA; Bötzel K; Höglinger GU; Koeglsperger T
    Front Genet; 2020; 11():572058. PubMed ID: 33101391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early synaptic dysfunction in Parkinson's disease: Insights from animal models.
    Schirinzi T; Madeo G; Martella G; Maltese M; Picconi B; Calabresi P; Pisani A
    Mov Disord; 2016 Jun; 31(6):802-13. PubMed ID: 27193205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease.
    Imbriani P; Martella G; Bonsi P; Pisani A
    Neurobiol Dis; 2022 Oct; 173():105851. PubMed ID: 36007757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.